Figure 1.
Postrelapse OS. (A) Postrelapse OS (PR-OS) among all evaluable patients. (B) Postrelapse OS based on their ibrutinib response before progression.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.